These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 667828)

  • 21. In vivo effects of methotrexate. Inhibition of DNA synthesis and cell death in sensitive and resistant L1210 ascites populations.
    Hofer KG
    Chemotherapy; 1972; 17(1):59-70. PubMed ID: 5009468
    [No Abstract]   [Full Text] [Related]  

  • 22. On the rational development of a new drug: the example of the fluorinated pyrimidines.
    Heidelberger C
    Cancer Treat Rep; 1981; 65 Suppl 3():3-9. PubMed ID: 7346154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Competitive binding radioassay for 5-fluorodeoxyuridine 5'-monophosphate in tissues.
    Murinson DS; Anderson T; Schwartz HS; Myers CE; Chabner BA
    Cancer Res; 1979 Jul; 39(7 Pt 1):2471-5. PubMed ID: 445447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetic alterations induced by 5-fluorouracil in bone marrow, intestinal mucosa, and tumor.
    Myers CE; Young RC; Chabner BA
    Cancer Res; 1976 May; 36(5):1653-8. PubMed ID: 1268826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical and pharmacokinetic effects of leucovorin after high-dose methotrexate in a murine leukemia model.
    Sirotnak FM; Donsbach RC; Moccio DM; Dorick DM
    Cancer Res; 1976 Dec; 36(12):4679-86. PubMed ID: 1087182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical rationale for the synergism of 5-fluorouracil and folinic acid.
    Moran RG; Keyomarsi K
    NCI Monogr; 1987; (5):159-63. PubMed ID: 2963229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell surface alterations associated with exposure of leukemia L1210 cells to fluorouracil.
    Kessel D
    Cancer Res; 1980 Feb; 40(2):322-4. PubMed ID: 7356515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro biological evaluation of the R and S isomers of 1-(Tetrahydrofuran-2-yl)-5-fluorouracil.
    Horwitz JP; McCormick JJ; Philips KD; Maher VM; Otto JR; Kessel D; Zemlicka J
    Cancer Res; 1975 May; 35(5):1301-4. PubMed ID: 1168096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
    Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL
    Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alteration of fluorouracil metabolism in human colon cancer cells by dipyridamole with a selective increase in fluorodeoxyuridine monophosphate levels.
    Grem JL; Fischer PH
    Cancer Res; 1986 Dec; 46(12 Pt 1):6191-9. PubMed ID: 2946402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening of Venezuelan poisonous plants for anticancer compounds. I--Comparison between carcinostatic activity on animal tumours and inhibition of protein and nucleic acid synthesis in cell incubations.
    González-Cadavid N; Cohen R; Salazar LM; Paramidani D
    Acta Cient Venez; 1980; 31(2):137-47. PubMed ID: 7468081
    [No Abstract]   [Full Text] [Related]  

  • 32. Threshold methotrexate concentration for in vivo inhibition of DNA synthesis in normal and tumorous target tissues.
    Chabner BA; Young RC
    J Clin Invest; 1973 Aug; 52(8):1804-11. PubMed ID: 4719662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism and selective effects of 1-beta-D-arabinofuranosylcytosine in L1210 and Host tissues in vivo.
    Chou TC; Hutchinson DJ; Schmid FA; Philips FS
    Cancer Res; 1975 Jan; 35(1):225-36. PubMed ID: 1109791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-trifluoroacetyladriamycin-14-valerate: additional mouse antitumor and toxicity studies.
    Parker LM; Hirst M; Israel M
    Cancer Treat Rep; 1978 Jan; 62(1):119-27. PubMed ID: 272230
    [No Abstract]   [Full Text] [Related]  

  • 35. Relative toxicity of methotrexate in several tissues of mice bearing Lewis lung carcinoma.
    Zaharko DS; Dedrick RL; Peale AL; Drake JC; Lutz RJ
    J Pharmacol Exp Ther; 1974 Jun; 189(3):585-92. PubMed ID: 4843162
    [No Abstract]   [Full Text] [Related]  

  • 36. [Studies on the antineoplastic action of N-methylisoindigotin].
    Ji XJ; Zhang FR; Liu Y; Gu QM
    Yao Xue Xue Bao; 1985 Apr; 20(4):247-51. PubMed ID: 4072694
    [No Abstract]   [Full Text] [Related]  

  • 37. [Disruption of DNA synthesis and structure of mouse L1210 leukemia cells, sensitive and resistant to 1-methyl-1 nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea in vivo].
    Kukushkina GV; Peretolchina NM; Minenkova EA; Verovskiĭ VN; Sof'ina ZP
    Biokhimiia; 1984 Jul; 49(7):1189-98. PubMed ID: 6477985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incorporation of iododeoxyuridine-125-I into the DNA of L1210 leukemia cells during tumor development.
    Her KG; Hughes WL
    Cancer Res; 1970 Jan; 30(1):236-43. PubMed ID: 5458962
    [No Abstract]   [Full Text] [Related]  

  • 39. Biochemical determinants of 5-fluorouracil response in vivo. The role of deoxyuridylate pool expansion.
    Myers CE; Young RC; Chabner BA
    J Clin Invest; 1975 Nov; 56(5):1231-8. PubMed ID: 1184747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of action and pharmacology studies with DTIC (NSC-45388).
    Loo TL; Housholder GE; Gerulath AH; Saunders PH; Farquhar D
    Cancer Treat Rep; 1976 Feb; 60(2):149-52. PubMed ID: 1260772
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.